Aptus Pharma (544529)
FAST GROWERScore breakdown: P/E: 0/3 · ROCE: 2/2 · Growth: 2/2 · Dividend: 0/1
Key Financials
| Current Price | ₹271.95 |
| Market Cap | ₹186.56 Cr |
| P/E Ratio | 52.7 |
| ROCE | 38.2% |
| ROE | —% |
| Dividend Yield | 0% |
| Profit Growth | 33.59% |
| Debt/Equity | — |
| Sales Growth | 47.34% |
| Sector | Pharmaceuticals & Biotechnology |
Aptus Pharma trades with a P/E ratio of 52.7, ROCE of 38.2%, profit growth of 33.59%.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer